Moshe Phillip

1988–2025 年に発表

129
論文数
21,651
被引用数
78
h 指数
118
i10 指数

被引用数

Moshe Phillip の年別被引用数1982 年: 被引用 1 件1991 年: 被引用 1 件1992 年: 被引用 1 件1993 年: 被引用 3 件1994 年: 被引用 1 件1995 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 5 件1999 年: 被引用 10 件2000 年: 被引用 23 件2001 年: 被引用 15 件2002 年: 被引用 27 件2003 年: 被引用 23 件2004 年: 被引用 57 件2005 年: 被引用 41 件2006 年: 被引用 56 件2007 年: 被引用 66 件2008 年: 被引用 76 件2009 年: 被引用 102 件2010 年: 被引用 76 件2011 年: 被引用 104 件2012 年: 被引用 89 件2013 年: 被引用 107 件2014 年: 被引用 138 件2015 年: 被引用 106 件2016 年: 被引用 120 件2017 年: 被引用 112 件2018 年: 被引用 192 件2019 年: 被引用 568 件2020 年: 被引用 748 件2021 年: 被引用 821 件2022 年: 被引用 715 件2023 年: 被引用 676 件2024 年: 被引用 1,041 件2025 年: 被引用 518 件2026 年: 被引用 27 件1983〜1990 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 1,942 件、この内訳の 23.5%イギリス: 引用元論文 696 件、この内訳の 8.4%イタリア: 引用元論文 519 件、この内訳の 6.3%ドイツ: 引用元論文 380 件、この内訳の 4.6%中国: 引用元論文 343 件、この内訳の 4.2%オーストラリア: 引用元論文 336 件、この内訳の 4.1%カナダ: 引用元論文 292 件、この内訳の 3.5%デンマーク: 引用元論文 260 件、この内訳の 3.2%フランス: 引用元論文 243 件、この内訳の 2.9%スペイン: 引用元論文 221 件、この内訳の 2.7%オランダ: 引用元論文 199 件、この内訳の 2.4%スウェーデン: 引用元論文 199 件、この内訳の 2.4%
0%23.5%その他 31.8%

分野

  • Medicine82.6%
  • Biochemistry, Genetics and Molecular Biology8.4%
  • Neuroscience1.7%
  • Health Professions1.7%
  • Nursing1.1%
  • Pharmacology, Toxicology and Pharmaceutics1.1%
  • その他3.4%

トピック

  • Diabetes Management and Research19.7%
  • Pancreatic function and diabetes9.9%
  • Diabetes and associated disorders9.3%
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients6.1%
  • Diabetes Treatment and Management5.2%
  • Diabetes Management and Education2.4%
  • その他47.4%

共著者

全論文

検索で開く
  1. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Helen R. Murphy, Revital Nimri, Kirsten Nørgaard, Christopher G. Parkin, Éric Renard, David Rodbard, Banshi Saboo, Desmond Schatz, Keaton Stoner, Tatsuiko Urakami, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2019 被引用: 3,797

  2. Continuous glucose monitoring and metrics for clinical trials: an international consensus statement

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julio Rosenstock, Banshi Saboo, Kohjiro Ueki, Guillermo E Umpierrez, Stuart A. Weinzimer, Moshe Phillip - The Lancet Diabetes & Endocrinology 2022 被引用: 725

  3. International Consensus on Use of Continuous Glucose Monitoring

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mauro Scharf, William V. Tamborlane, Stuart A. Weinzimer, Moshe Phillip - Diabetes Care 2017 被引用: 2,026

  4. Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical Practice

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin de Bock, Daniel J. DeSalvo, J. Hans DeVries, Klemen Dovč, Francis J. Doyle, Laya Ekhlaspour, Naama Fisch Shvalb, Gregory P. Forlenza, Geraldine Gallen, Satish K. Garg, Dana Gershenoff, Linda Gonder‐Frederick, Ahmad Haidar, Sara Hartnell, Lutz Heinemann, Simon Heller, Irl B. Hirsch, Korey K. Hood, Diana Isaacs, David C. Klonoff, Olga Kordonouri, Aaron J. Kowalski, Lori M. Laffel, Julia Lawton, Rayhan Lal, Lalantha Leelarathna, David M. Maahs, Helen Murphy, Kirsten Nørgaard, David N. O’Neal, Sean M. Oser, Tamara K. Oser, Éric Renard, Michael C. Riddell, David Rodbard, Steven J. Russell, Desmond Schatz, Viral N. Shah, Jennifer L. Sherr, Gregg D. Simonson, R. Paul Wadwa, Candice Ward, Stuart A. Weinzimer, Emma G. Wilmot, Tadej Battelino - Endocrine Reviews 2022 被引用: 402

  5. A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelly L. Close, Curtiss B. Cook, Thomas Danne, Francis J. Doyle, Angela Drincic, Kathleen Dungan, Steven V. Edelman, Niels Ejskjær, Juan Espinoza, G. Alexander Fleming, Gregory P. Forlenza, Guido Freckmann, Rodolfo J. Galindo, Ana María Gómez, Hanna A. Gutow, Lutz Heinemann, Irl B. Hirsch, Thanh D. Hoang, Roman Hovorka, Johan Jendle, Linong Ji, Shashank Joshi, Michaël Joubert, Suneil K. Koliwad, Rayhan Lal, M. Cecilia Lansang, Wei-An Lee, Lalantha Leelarathna, Lawrence A. Leiter, Marcus Lind, Michelle L. Litchman, Julia K. Mader, Katherine Mahoney, Boris Mankovsky, Umesh Masharani, Nestoras Mathioudakis, Alexander Yur'evich Mayorov, Jordan Messler, Joshua D. Miller, Viswanathan Mohan, James H. Nichols, Kirsten Nørgaard, David N. O’Neal, Francisco J. Pasquel, Athena Philis‐Tsimikas, Thomas R. Pieber, Moshe Phillip, William H. Polonsky, Rodica Pop‐Busui, Gerry Rayman, Eun‐Jung Rhee, Steven J. Russell, Viral N. Shah, Jennifer L. Sherr, Koji Sode, Elias K. Spanakis, Deborah J. Wake, Kayo Waki, Amisha Wallia, Melissa E. Weinberg, Howard Wolpert, Eugene E. Wright, Mihail Zilbermint, Boris Kovatchev - Journal of Diabetes Science and Technology 2022 被引用: 276

  6. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet 2021 被引用: 328

  7. Insulin dose optimization using an automated artificial intelligence-based decision support system in youths with type 1 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lori M. Laffel, Michelle L. Katz, Elvira Isganaitis, Sanjeev N. Mehta, Heidi Quinn, Nisha Naik, Zijing Guo, Lisa K. Volkening, Robert H. Slover, Gregory P. Forlenza, R. Paul Wadwa, G. Todd Alonso, Laurel H. Messer, Lindsey Towers, Katie Thivener, Cari Berget, Samantha Lange, Emily Jost, Maria Rossick-Solis, Desmond Schatz, Michael J. Haller, Paul Hiers, Laura M. Jacobsen, Madison B. Smith, Anastasia O’Neill, Jennifer Hosford, Alexis Perry, Stuart A. Weinzimer, Eda Cengiz, Jennifer L. Sherr, Kathryn Gibbons, Lori Carria, Melinda Zgorski, Thomas Danne, Torben Biester, Olga Kordonouri, Thekla von dem Berge, Sarah Biester, K Remus - Nature Medicine 2020 被引用: 237

  8. Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jeppe Gram, Claus Bogh Juhl, Janne Hukkanen, Jorma Lahtela, Leo Niskanen, Donal O’Shea, Timothy O’Brien, Séamus Sreenan, Julio Wainstein, Moshe Phillip, Hilla Knobler, Francesco Dotta, Pier Marco Piatti, Roberto Trevisan, Agostino Gnasso, Hanne L. Gulseth, John Cooper, Ewa Pańkowska, Monika Łukaszewicz, Bogumił Wolnik, Isabel Manita, Olinda Marques, Cristina Roque, Rosa Maria Príncipe, Celestino Neves, Susana Heitor, L. A. Ruyatkina, I. V. Dvoryashina, Gulnar Vagapova, Lidiya Belousova, M. Sergeeva-Kondrachenko, А. Б. Песков, Elena Frolova, Albina Golovach, М. А. Куницына, N Krasnopeeva, Irina Ipatko, Carmen De la Cuesta, Francisco J. Tinahones, Mercedes Rigla, Juan Francisco Merino-Torres, Luis Alberto Gómez, Mercè Fernández, Rafael Simó, Mikael Rydén, Johan Jendle, Karin Filipsson, Björn Eliasson, Borys Mankovsky, Iurii Lymar, Liubov Sokolova, Galyna Myshanych, Tetiana Zlova, М.V. Vlasenkо, Petro Kuskalo -, Hamish Courtney, Colin Dayan, Patrick English, Simon Heller, A.B. Johnson, Sunil Nair, Richard David Leslie, Parth Narendran, Nick Oliver, Shenaz Ramtoola, J. H. F. Shaw, Adie Viljoen, Amer Al‐Karadsheh, Jean M. Dostou, Sumana Gangi ほか 13 名 - The Lancet Diabetes & Endocrinology 2021 被引用: 178

  9. International Consensus on Risk Management of Diabetic Ketoacidosis in Patients With Type 1 Diabetes Treated With Sodium–Glucose Cotransporter (SGLT) Inhibitors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Diabetes Care 2019 被引用: 356

  10. Glycaemic management in diabetes: old and new approaches

    著者: , , , , , - The Lancet Diabetes & Endocrinology 2021 被引用: 129

  11. Consensus Guidance for Monitoring Individuals With Islet Autoantibody–Positive Pre-Stage 3 Type 1 Diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetes Care 2024 被引用: 68

  12. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Thomas Schaum, Diethelm Tschoepe, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban, Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro, Stobschinski de Alba, Carlos Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández ほか 70 名 - The Lancet Diabetes & Endocrinology 2017 被引用: 292

  13. Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study

    著者: , , , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2022 被引用: 102

  14. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Diethelm Tschöpe, Thomas Schaum, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro Stobschinski de Alba, Carlos Eduardo Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández, Roberto Araujo Silva, Efraín Villeda-Espinosa ほか 68 名 - Diabetes Care 2018 被引用: 238

  15. Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Heba M. Ismail, Laura M. Jacobsen, Suzanne Bennett Johnson, Leslie E. Kolb, Olga Kordonouri, Karin Lange, Robert W. Lash, Åke Lernmark, Ingrid Libman, Markus Lundgren, David M. Maahs, M. Loredana Marcovecchio, Chantal Mathieu, Kellee M. Miller, Holly K. O’Donnell, Tal Oron, Shivajirao P. Patil, Rodica Pop‐Busui, Marian Rewers, Stephen S. Rich, Desmond Schatz, Rifka Schulman‐Rosenbaum, Kimber M. Simmons, Emily K. Sims, Jay S. Skyler, Laura Smith, Cate Speake, Andrea K. Steck, Nicholas Thomas, Ksenia N. Tonyushkina, Riitta Veijola, John M. Wentworth, Diane K. Wherrett, Jamie Wood, Anette‐Gabriele Ziegler, Linda A. DiMeglio - Diabetologia 2024 被引用: 58

  16. Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes

    著者: , , , , , - Diabetes Care 2011 被引用: 491

  17. Short and tall stature: a new paradigm emerges

    著者: , , , , , , - Nature Reviews Endocrinology 2015 被引用: 319

  18. The Digital/Virtual Diabetes Clinic: The Future Is Now—Recommendations from an International Panel on Diabetes Digital Technologies Introduction

    著者: , , , , , , , , , , , - Diabetes Technology & Therapeutics 2020 被引用: 143

  19. Lived Experience of Advanced Hybrid Closed-Loop Versus Hybrid Closed-Loop: Patient-Reported Outcomes and Perspectives

    著者: , , , , , , , , , , , , , , , - Diabetes Technology & Therapeutics 2021 被引用: 56

  20. Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

    著者: , , , , , , , - Diabetes Care 2006 被引用: 544

  21. MD-Logic Artificial Pancreas System

    著者: , , , , - Diabetes Care 2010 被引用: 264

  22. Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials

    著者: , , , , , , , , , , , - The Lancet Diabetes & Endocrinology 2020 被引用: 78

  23. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: Variations among countries and physicians

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas Danne, Eran Atlas, Moshe Phillip - Diabetes Obesity and Metabolism 2018 被引用: 78

  24. Long‐term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52‐week outcomes from the DEPICT ‐1 and ‐2 studies

    著者: , , , , , , , , , , , , , , - Diabetes Obesity and Metabolism 2020 被引用: 40